Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
12/2007
12/25/2007US7312226 1-Benzo[1.3]dioxol-5-yl methyl-3-[2-(6,7-dimethoxy-quinazolin-4ylamino)-pyrimidin-5yl]-thiourea (14); anticarcinogenic, antitumor, antdiabetic, antiproliferative agent
12/25/2007US7312222 Heterocyclic piperidines as modulators of chemokine receptor activity
12/25/2007US7312221 Therapeutic treatment of endotoxic shock with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating psoriasis, arthritis, osteoarthritis, glomerulonephriti, autoimmune disorder include diabetes, asthma, or multiple sclerosis
12/25/2007US7312220 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
12/25/2007US7312218 For use as anticoagulant agents for therapy of thromboembolic disorders; 6-chloro-naphthalene-2-sulfonic acid [1-(1-cyclopentyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide; )-2-methyl-benzothiazole-6-sulfonic acid [1-(1-isopropyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide
12/25/2007US7312210 7-Methoxy-8-{3-[4-(2-oxo-2H-4-chromenyl)piperazino]propyl}-oxy-(11aS)-1,2,3,11a-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one(5a); antitumor, anticarcinogenic agents;
12/25/2007US7312209 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives
12/25/2007US7312200 9-ketospinosyn derivatives
12/25/2007US7312180 Substituted 4-(4-trifluoromethylpyrazolyl)pyrimidines
12/25/2007US7312038 Photocleavable bioreactive agents
12/21/2007WO2007146225A2 Heterocyclic aspartyl protease inhibitors
12/21/2007WO2007146072A2 Process for synthesizing piperazine-piperidine compounds
12/21/2007WO2007145282A1 Therapeutic or prophylactic agent for allergic dermatitis
12/21/2007WO2007144487A2 Dual molecules containing a peroxide derivative, their synthesis and therapeutic uses
12/21/2007WO2007144129A2 Pyrrolidine derivatives useful against diseases that depends on activity of renin
12/21/2007WO2007144128A1 Pyrrolidine compounds as renin inhibitors
12/21/2007WO2007143951A1 COMPOUNDS WITH THE ACTIVITY OF PPARγ AGONIST AND APPLICATION THEREOF
12/21/2007WO2007123942A3 Benzodioxane and benzodioxolane derivatives and uses thereof
12/21/2007WO2007123939A3 Novel arylamino n-heteraryls as mek inhibitors
12/21/2007WO2007122634A3 Pyrimidinediones as tyrosine kinase inhibitors
12/21/2007WO2007117607A3 Quinazolines for pdk1 inhibition
12/21/2007WO2007105058A3 Pyrazole compounds
12/21/2007WO2007063418A3 Substituted indole compounds having nos inhibitory activity
12/21/2007WO2007062078A3 Thrombopoietin activity modulating compounds and methods
12/21/2007WO2005030712A8 Thrombin receptor antagonists
12/21/2007CA2665940A1 Dual molecules containing a peroxide derivative, their synthesis and therapeutic uses
12/21/2007CA2655286A1 Therapeutic or prophylactic agent for allergic dermatitis
12/21/2007CA2654979A1 Pyrrolidine compounds as renin inhibitors
12/21/2007CA2654699A1 Benzamide derivatives and uses related thereto
12/21/2007CA2654515A1 Substituted 3-cyanopyridines as protein kinase inhibitors
12/21/2007CA2653650A1 Heterocyclic aspartyl protease inhibitors
12/21/2007CA2653524A1 Pyrrolidine derivatives useful against diseases that depends on activity of renin
12/21/2007CA2650934A1 Processes for synthesizing piperazine-piperidine compounds
12/21/2007CA2650666A1 Substituted cyanopyridines as protein kinase inhibitors
12/20/2007US20070293674 Novel Saperconazole Crystalline Forms and Related Processes, Pharmaceutical Compositions and Methods
12/20/2007US20070293555 4-methoxy-benzoic acid 1-imidazol-1-yl methyl-2-(4-fluorophenoxy)-ethyl ester; N-[(1-imidazol-1-yl methyl)-2-phenoxy-ethyl]-4-iodo-benzamide; cancer, inflammation, septic shock, infertility, preterm labor, pain, or an ischemia
12/20/2007US20070293540 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition
12/20/2007US20070293524 Salts, hydrates, solvatesand/or N-oxides; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors; inhibiting an Fc receptor signal transduction cascade
12/20/2007US20070293523 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents
12/20/2007US20070293522 2,4-pyrimidinediamine compounds and their uses
12/20/2007US20070293521 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents
12/20/2007US20070293520 2,4-pyrimidinediamine compounds and their uses
12/20/2007US20070293501 Thioalkeneamides as Transketolase Inhibitors
12/20/2007US20070293496 Nitrogen containing heterocyclic compounds and medicines containing the same
12/20/2007US20070293495 to treat Alzheimer's disease,Down syndrome and the other diseases associated with amyloid deposition; thiomethane, sulfinylmethane or sulfonylmethane compounds; 5-Chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]-2-(4'-hydroxypiperidin-1'-yl)pyridine
12/20/2007US20070293399 Substituted diamino-1,3,5-triazines, processes for their preparation and their use as herbicides and crop growth regulators
12/20/2007US20070292933 Inhibitors of serine proteases, particular HCV NS3-NS4A protease
12/19/2007EP1866315A1 1,2,4-triazole derivatives and their use as oxytocin antagonists
12/19/2007EP1866284A1 Biphenyl compounds useful as muscarinic receptor antagonists
12/19/2007EP1865991A2 Cytotoxic compounds and conjugates comprising duocarmycins with cleavable substrates
12/19/2007EP1865958A2 Pharmacokinetically improved compounds
12/19/2007EP1865774A1 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
12/19/2007EP1546152B1 Epothilone derivatives
12/19/2007EP1490062B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/19/2007EP1453806B1 Aminotetralin derivatives as muscarinic receptor antagonist
12/19/2007EP1347967B1 Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists
12/19/2007EP1326856B1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity
12/19/2007EP1165068B1 C10 heterosubstituted acetate taxanes as antitumor agents
12/19/2007EP1032556B1 Pharmaceutically active compounds and methods of use
12/19/2007CN101090739A 1,4-bis(carboxymethyl)-6-[bis(carboxymethyl)amino]-6-methyl-perhydro-1,4-diazepine (aazta) derivatives as ligands in high relaxivity contrast agents for use in magnetic resonance imaging (mri)
12/19/2007CN101089010A 2'-fluoroncucleosides
12/19/2007CN101088998A Trans-9,10-dehydroepothilone c and d, analogs thereof and methods of making the same
12/19/2007CN100356270C Organophotoreceptor with an epoxy-modified charge transport compound having an azine group
12/19/2007CN100355731C Pyridinum derivatives for management of aging-related and diabetic vascular complications, process for their prepn. and therepeutic uses thereof
12/19/2007CN100355728C Inhibitors of dipeptidyl peptidase IV
12/18/2007US7309800 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
12/18/2007US7309793 Benzopyran derivatives substituted with a benzimidazole derivative, pharmaceutically acceptable salts therof, their preparations and pharmaceutical compositions containing them
12/18/2007US7309716 Inhibitors of voltage-gated sodium channels; acute, chronic, neuropathic, or inflammatory pain such as femur cancer pain; non-malignant chronic bone pain; rheumatoid arthritis; osteoarthritis; spinal stenosis; neuropathic low back pain; neuropathic low back pain; myofascial pain syndrome; fibromyalgia
12/18/2007US7309708 Serine protease inhibition via N-(distubstituted aminomethylcarbonyl)-2-[N-(1-sulfonylamido-1-cyclopropanyl)amido]pyrrolidines
12/18/2007US7309701 inhibitors of glycogen synthase kinase-3 beta; treatment of diabetes or neurodegenerative diseases such as Alzheimer's disease; 6-(2-butylamino-pyrimidin-4-yl)-3-oxo-2,3-dihydro-pyridazine-4-carboxylic acid (3-pyridin-3-yl-propyl)-amide, as example
12/18/2007CA2217074C Process for detecting target nucleic acid, process for quantifying the same, and pyrylium compound for chemiluminescence analysis
12/13/2007WO2007142585A1 Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia
12/13/2007WO2007142584A1 Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia
12/13/2007WO2007142583A1 Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia.
12/13/2007WO2007141318A1 2,5-disubstituted piperidines
12/13/2007WO2007141039A1 1,3-disubstituted 4-methyl-1h-pyrrole-2-carboxamides and their use for the manufacture of medicaments
12/13/2007WO2007119001A3 Aminomethyl pyridine derivatives, method for preparing same and therapeutic use thereof
12/13/2007WO2007117982A3 Organic compounds
12/13/2007WO2007105154A3 Antibiotic compounds
12/13/2007WO2007078813A3 2-AMINO-5-PIPERIDINYLIMIDAZOLONE COMPOUNDS AND USE THEREOF FOR β-SECRETASE MODULATION
12/13/2007WO2007044796A3 Pyridazinone compounds as calcilytics
12/13/2007US20070287732 highly potent; side effect reduction; for the treatment of diseases of the respiratory, urinary and gastrointestinal systems; 3-(2-Methoxy-5-methylphenyl)-3-phenylpropionic acid-(3-benzyl-3-azabicyclo[3.1.0]hex-6-yl-carbamoyl)methyl ester; condensation; deprotection
12/13/2007US20070287710 Piperidinediyl-containing sulfonamide; NPY Y5 receptor antagonist activity; antiobesity agent or anorectic agent
12/13/2007US20070287708 Substituted 3-cyanopyridines as protein kinase inhibitors
12/13/2007CA2660667A1 2,5-disubstituted piperidines
12/13/2007CA2654147A1 Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia
12/13/2007CA2654138A1 Novel compounds
12/13/2007CA2653655A1 Organic compounds
12/13/2007CA2653526A1 1,3-disubstituted 4-methyl-1h-pyrrole-2-carboxamides and their use for the manufacture of medicaments
12/12/2007EP1864981A1 Thrombopoietin mimetics
12/12/2007EP1864980A1 Antifungal agent containing pyridine derivative
12/12/2007EP1864975A2 Novel compounds
12/12/2007EP1863805A1 Pyrimidine compounds having tie2 (tek) inhibitory activity
12/12/2007EP1863800A2 Synthesis of avrainvillamide, stephacidin b, and analogues thereof
12/12/2007EP1863799A1 Cgrp-antagonists, process for their preparation as well as their use as medicaments
12/12/2007EP1863798A1 Indole derivatives
12/12/2007EP1863784A1 Substituted aminoalkyl- and amidoalkyl-benzopyran derivatives
12/12/2007EP1863763A1 3,4,5-substituted piperidines as renin inhibitors
12/12/2007EP1863483A1 Bicyclic pyrazole compounds as antibacterial agents
12/12/2007EP1863477A1 3,4-substituted pyrrolidine derivatives for the treatment of hypertension
1 ... 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 ... 694